$TER

Smith Gregory Stephen sold $1.7M of TER

Smith Gregory Stephen (President and CEO) sold 4,000 shares of TERADYNE, INC (TER) at $425.00 ($1.70M total) on 2026-08-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Gregory Stephen
Published Aug 18, 2026, 3:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 4:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TER
Neutral
high confidence
Mentioned
$TER
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

The only new information is the disclosed sale size, price, and post-transaction holdings; it does not include any new guidance, contract, or regulatory development.

02

Market read

Traders may note the CEO’s scheduled sale optics, but there is no fundamental update to drive repricing.

03

What to watch

The disclosure does not indicate whether the sale was driven by diversification, taxes, or scheduled liquidity needs; 10b5-1 timing can decouple sales from near-term outlook.

Relevance 5/10Novelty 3/10Timing: filed today on SEC EDGAR, covering a sale dated 2026-08-17

Background

The article is an SEC Form 4 insider transaction report for Teradyne, Inc. (TER) by its President and CEO.

Company-level read

Ticker impact

$TERNeutralHigh confidence
Context

Teradyne CEO sold 4,000 shares in an open-market transaction for about $1.7M under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is more about optics than fundamentals.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan, and the article provides no new company-specific operational or financial information.

Market effects

No direct sector read-through; insider sales under 10b5-1 are typically not interpreted as earnings or guidance signals.

None.

None.

Counterpoint

Some traders may treat large CEO sales as a mild bearish signal, even if 10b5-1 reduces interpretability.

Key entities

  • TERADYNE, INC

    Public company whose CEO filed the Form 4 insider sale disclosure.

  • Smith Gregory Stephen

    President and CEO who sold 4,000 shares at $425/share under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TERHigh

Why is Teradyne stock sliding today?

Teradyne (TER) stock fell 3.9% after Baird downgraded it to Neutral with a $420 price target, citing stretched valuation and concerns over AI and hyperscaler spending sustainability. The firm argues GPU testing catalyst is priced in and next growth drivers are too distant. TER's decline contrasts with broader market gains, highlighting company-specific pressures.

$METAMed

Stocks making the biggest moves midday: Meta, Amylyx, Baidu, Klarna, Coherent, Sandisk & more

Amylyx Pharmaceuticals shares rose 53% after its avexitide treatment met trial endpoints. Meta Platforms fell 3% amid a lawsuit. Carvana dropped 3% after director stock sales. UGI Corporation surged 12% on a $9B KKR bid report. AI-related stocks declined. Klarna fell 21% on weak guidance. Baidu dropped 12% on earnings miss. Home Depot rose slightly on earnings beat. Fabrinet fell 20% on margin concerns. Memory stocks declined. Duolingo rose 7% on an upgrade.

$OUSTMed

Robotics Stocks Rally as Unitree’s 8000X Oversubscribed IPO Draws Frenzied Demand: Ouster, Symbotic, and Teradyne in Focus

Robotics and physical AI stocks rose after China’s Unitree Robotics Shanghai IPO reportedly drew 8,000x retail oversubscription. In U.S. trading, Ouster gained 7% near $45, Symbotic rose 3% to about $41, and Teradyne added 3% to about $376. Ouster reported Q2 revenue of $54.63M (+55.9% YoY) and 17,000+ sensors; Symbotic has a ~$22.5B backlog. Analysts’ consensus targets cited $58 for OUST and $450 for TER.

$TERMed

5 Revealing Analyst Questions From Teradyne’s Q2 Earnings Call

Teradyne reported Q2 revenue of $1.33B vs $1.22B expected and adjusted EPS of $2.47 vs $2.05, citing AI-driven demand across semiconductor test, product test, and robotics. CEO Gregory Smith said over 60% of revenue is AI-related. Q3 guidance calls for $1.25B revenue and $2.00 adjusted EPS at midpoint. Analysts asked about test equipment share, wafer-to-data-center strategy, memory drivers, and CPU vs GPU testing.